Thyroid Medication Recall 2026: Affected Lots and What to Do

Affiliate Disclosure: This article contains affiliate links. If you buy through one of them we may earn a commission, at no extra cost to you. We only recommend products we genuinely believe in. As an Amazon Associate I earn from qualifying purchases.

Medical Disclaimer: This content is for informational and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions or starting any new treatment.

Three separate thyroid medication recalls have been announced in the past twelve months, and all three involve the same drug: levothyroxine, the standard T4 replacement taken by roughly 20 million Americans. If you take thyroid medication, the practical questions are which lots are affected, how to read the label on your own bottle, and what to do before you stop taking anything.

Quick Answer

As of October 2026, the active thyroid medication recalls in the United States all involve levothyroxine sodium tablets. None of them involve Synthroid, the most widely used brand.

• Major Pharmaceuticals (July 2026) — 12 lots across seven strengths, recalled for subpotency. FDA Class II.
• Alvogen Thyro-Tabs (December 2025) — one lot labelled 150 mcg that actually contained 88 mcg tablets. FDA Class II.
• Pfizer Levoxyl (August 2025) — one lot of 50 mcg, recalled for subpotency. FDA Class II.
• Lupin (December 2024) — one lot of 75 mcg, failed impurity and degradation specifications. Recall terminated February 2026.

If your bottle is affected, do not stop your medication on your own. Call your pharmacy, get a replacement from a different lot, and ask your doctor whether you need a thyroid blood test.

What Counts as a Thyroid Medication Recall

The FDA grades drug recalls by the risk they pose. Class I means the product could cause serious harm or death. Class II — the grade used for every recall listed above — means the product may cause temporary or medically reversible harm, and the chance of serious harm is remote. Class III means the product is unlikely to cause harm at all.

Most thyroid recalls are voluntary actions taken by the manufacturer after routine stability testing. That testing is not a formality: it is how a company discovers that tablets shipped months ago have lost potency on the shelf.

The recurring word in these recalls is subpotent. A subpotent tablet is not contaminated and it is not poisonous — it simply contains less active ingredient than the label promises. For most drugs that would be a minor inconvenience. For thyroid hormone it matters, because levothyroxine is a narrow therapeutic index drug: the gap between a dose that works and a dose that does not is small. A pill labelled 75 mcg that delivers 60 mcg can quietly push a well-controlled patient back into hypothyroidism.

Every Thyroid Medication Recall Since Late 2024

Two details are easy to miss. The Alvogen recall was not a potency problem at all — a pharmacy received a bottle labelled 150 mcg that contained 88 mcg tablets, which is a mix-up rather than a weak batch. And the Lupin lot has been off the market since early 2026, so it should no longer be in circulation unless you keep old bottles at home.

Why Levothyroxine Is Recalled So Often

Levothyroxine accounts for the overwhelming majority of thyroid prescriptions, so it is also the drug most likely to generate a recall simply because there is more of it in circulation. Three things make it unusually recall-prone:

• The therapeutic window is narrow. Small potency losses produce real symptoms, so regulators act on deviations that would be tolerated in other drugs.
• It is unstable in storage. Potency depends on moisture, temperature and light, which is why recalls often surface from stability testing rather than from patient reports.
• It is made by many manufacturers at once. Multiple generic producers mean multiple supply chains, and a problem in any one of them affects a subset of patients who may not know which company made their tablets.

That last point is the practical one: the manufacturer on your label may change between refills without anyone telling you, because pharmacists substitute freely within the same strength.

Liothyronine, Desiccated Thyroid and Antithyroid Drugs

Levothyroxine is not the only thyroid medicine on the shelf. The other three groups have their own recall history, and the same checking routine applies to each:

• Liothyronine (T3) — sold as Cytomel and as generics. Potency problems are handled the same way as levothyroxine, and substitution between brands can change how you feel even when the dose is identical.
• Desiccated thyroid — natural products such as NP Thyroid and Armour Thyroid are made from animal tissue, which makes consistent potency harder to guarantee than with a synthetic tablet.
• Antithyroid drugs — methimazole and propylthiouracil (PTU) treat hyperthyroidism rather than replace hormone. Recalls here tend to involve contamination or labelling rather than potency.

Because recall status changes from week to week, the reliable move is to check the FDA recall database for the specific drug and manufacturer on your label rather than relying on any article, including this one.

How to Check Your Own Bottle in Four Steps

1. Find the manufacturer. Look for the company name on the manufacturer’s label, not the pharmacy’s. Major Pharmaceuticals sometimes appears as “Major” or “Major Rugby”.
2. Find the lot number. Look for “LOT” or “Batch” followed by a number. On a standard bottle it is printed on the pharmacy label or the manufacturer’s label. On a blister pack it is on the outer carton or the backing foil. On bag-packaged tablets the lot usually carries an “A” or “B” suffix.
3. Match strength and lot together. A lot number only matters alongside the strength — the same recall can cover different lots at 25 mcg and 150 mcg.
4. Call the pharmacy if you cannot tell. Pharmacies keep purchasing records and can identify the manufacturer and lot for your exact prescription. This is a two-minute phone call and it is the fastest way to a definitive answer.

You can also match the NDC number printed on the carton, which identifies the product and package size even when the lot number has worn off.

What to Do If Your Medication Is Recalled

1. Do not stop taking it abruptly. Sudden withdrawal can worsen hypothyroidism, and in severe, long-standing cases can contribute to a myxedema crisis. The risk of a few more days on a weak tablet is lower than the risk of stopping without a plan.
2. Ask for a replacement from a different lot or manufacturer. This is usually straightforward and is often free.
3. Ask your doctor about a thyroid blood test. A TSH (and usually free T4) taken six to eight weeks after you switch gives a reliable picture. Testing immediately after a switch can be misleading.
4. Report the problem. The FDA MedWatch programme is how patterns get detected. Your pharmacist can file on your behalf.

Symptoms of an Under-Treated Thyroid

If you have been taking a subpotent tablet, your hormone level may have drifted below your therapeutic range. Watch for a return of symptoms you recognise from before treatment:

• Early: fatigue that does not improve with rest, unexplained weight gain of a few pounds over several weeks, feeling cold when others are comfortable, constipation.
• Moderate: dry skin and brittle nails, hair thinning, muscle aches and joint stiffness, poor concentration, low mood.

The opposite pattern matters too. Palpitations, anxiety, insomnia and unexpected weight loss suggest over-replacement, which is a different problem and also needs a dose review.

When to See a Doctor

• Chest pain, breathlessness, or fainting — seek urgent care.
• Severe lethargy, confusion, a very slow heartbeat, or a low body temperature. This combination can signal myxedema crisis and is a medical emergency.
• You are pregnant or planning a pregnancy. Thyroid requirements rise early in pregnancy and a subpotent tablet is more consequential.
• Your TSH is outside the reference range on a recent blood test.
• You have been switched between manufacturers and your symptoms changed.

Related reading

Related reading: the full levothyroxine recall breakdown, lot by lot, thyroid symptoms worth investigating, why you might still feel tired, and how thyroid hormone affects metabolism.

Sources

Sources:

• US Food and Drug Administration — Drug Recalls database
• US Food and Drug Administration — MedWatch reporting programme
• American Thyroid Association — Hypothyroidism
• Endocrine Society — Thyroid hormone replacement guidance
• National Institutes of Health, DailyMed — levothyroxine product labelling
• MHRA Drug Safety Update — levothyroxine potency

Frequently Asked Questions